D-1343-2014 Class II Terminated
FDA drug recall D-1343-2014 was initiated by Fresenius Medical Care Holdings, Inc. on Apr 14, 2014 and is designated Class II. Reason for recall: Cross Contamination with Other Products: Potential for contaminant on the cotton packaging inside the bottle. Chemical analysis of the contaminant found on the cotton was identified as a formulation… The recall status is terminated (terminated Aug 13, 2015). Affected quantity: 14,496 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- May 28, 2014
- Initiation Date
- Apr 14, 2014
- Termination Date
- Aug 13, 2015
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 14,496 bottles
Product description
phosLo (calcium acetate) GelCaps, 667 mg, 200-count bottle, Rx only, Manufactured for Fresenius Medical Care North America, Waltham, MA 02451, NDC 0781-2081-02
Reason for recall
Cross Contamination with Other Products: Potential for contaminant on the cotton packaging inside the bottle. Chemical analysis of the contaminant found on the cotton was identified as a formulation of 4% Trimipramine methanesulfonate - a tricyclic antidepressant..
Distribution pattern
PA
Code information
Lot # 13064, 13065, 13066; Exp. 08/18
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1343-2014
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026